Isodiol Hemp & CBD Articles

Isodiol International Inc. Announces Appointment of New Chief Financial Officer

August 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company”), a global CBD innovator and leader specializing in hemp-based health and wellness products, announces that Mr. Eli Dusenbury, CPA, CA, has been appointed as the Company’s new Chief Financial Officer.  Mr. Dusenbury has over…

Read More

Isodiol International Inc. Enters Hemp Beer and Related Functional Beverage Sector Through Its Subsidiary, IsoBev

August 20, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce the progress of its months-long efforts to develop new hemp-based beers and functional beverages. In May 2018, IsoBev Inc. (“IsoBev”), a wholly…

Read More

Isodiol International Inc. Applauds the World Health Organization on Its Recommendation That Pure CBD Should Not Be Scheduled Within International Drug Control Conventions

August 17, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”),a global CBD leader and innovator, applauds the World Health Organization’s (WHO) historic recommendation, at the conference in Geneva, that pure CBD should not be scheduled within the International Drug Control Conventions. Some…

Read More

Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry

August 16, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, in conjunction with Livecare is proud to announce the launch of ISOCare in North American and Latin American markets. ISOCare is an innovative secure…

Read More

Isodiol International Inc. Announces Former IFBB Professional Bodybuilder, David Hawk, Joins Iso-Sport Management Team

August 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is proud to announce that it has entered into an agreement with David Hawk, fitness expert and a former IFBB professional bodybuilder, who ranked…

Read More

ISODIOL INTERNATIONAL INC. APPOINTS BARINDER RASODE TO ITS ADVISORY BOARD

August 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is pleased to announce the appointment of Barinder Rasode to its advisory board. She will be focused on assisting the Company with its advocacy…

Read More

Isodiol International Inc. Announces Partnership Between ISO-Sport and ALTIS, an Elite Training Environment for Athletes & Coaches

August 7, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce that Iso-Sport has entered into an agreement with ALTIS LLC (“Altis”), an Arizona based company that was built to bring Track &…

Read More

Marvin Washington Tackles Cannabis On The Green Rush Podcast

On this week’s episode of The Green Rush podcast, hosts Anne Donohoe and Lewis Goldberg spend time with Super Bowl champion and cannabis educator and activist Marvin Washington. After an impressive 11 year career on the NFL, Marvin has truned his attention to the cannabis industry as an entrepreneur, an…

Read More

ISODIOL INTERNATIONAL INC. ANNOUNCES LETTER OF INTENT FOR ONGOING SUPPLY OF PHARMACEUTICAL GRADE CANNABIDIOL TO PURE GLOBAL CANNABIS INC. FROM BSPG LABORATORIES, LTD.

August 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader specializing in the development of pharmaceutical drug deliveries, health and wellness products and now supporting the pharmaceutical industry at large with BSPG Laboratories, LTD. recently…

Read More

Isodiol International Inc. Introduces Isoderm Direct Effects Technology Nationally Via PBS Television

July 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient (API) for…

Read More
Fiscal Year Report Newsletter

Isodiol International Inc. Reports Fiscal Year 2018 Audited Financial Results

[vc_row][vc_column width=”1/12″][/vc_column][vc_column width=”10/12″][vc_column_text]July 30, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient…

Read More

Isodiol International Inc. Finalizes Share Consolidation

July 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API)…

Read More

Isodiol International Inc. Outlines Strategy for Balanced, Long-Term Growth to Increase Shareholder Value

June 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, announces plans to pursue a focused business strategy designed to improve its market leadership and fully leverage the potential of recent acquisitions. “Over the past…

Read More

Isodiol International Inc. Applauds the FDA’s Decision to Recognize the Medical Benefits of CBD at Higher Concentrations and Announces Corporate Restructure

June 27, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), applauds the FDA’s decision on the long-anticipated…

Read More

ISODIOL INTERNATIONAL INC. ANNOUNCES BINDING AGREEMENT TO ACQUIRE 51% OF ROUND MOUNTAIN TECHNOLOGIES, LLC AND COMMENCES CERTIFIED ORGANIC HEMP FARMING IN NEVADA

June 12, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical…

Read More